Mebendazole Shortage Update: What Patients Need to Know in 2026

If you've been struggling to fill a mebendazole prescription, you're probably wondering: is this drug actually in shortage? The short answer in 2026 is complicated. Mebendazole — sold in the US exclusively as brand-name Emverm — is not formally listed on the FDA Drug Shortage Database. But that doesn't mean it's easy to find or afford.

Current Mebendazole Availability Status in 2026

As of early 2026, the FDA has not listed mebendazole as an active drug shortage. However, patients across the country continue to report significant difficulty obtaining the medication. The challenges patients are experiencing come from several directions:

• Price: The retail price of Emverm (the only US-marketed form of mebendazole) ranges from $4,287 to over $5,258 for just 2 tablets. This is one of the highest prices for any common antiparasitic medication.
• No generic: Generic mebendazole was discontinued in the US around 2011. As of 2026, there is still no FDA-approved generic mebendazole commercially available in the US, leaving patients with only the brand-name option.
• Inconsistent stocking: Because Emverm is expensive and has relatively low demand compared to blockbuster medications, many pharmacies — especially large chain stores — don't keep it on their shelves routinely.

A Brief History: What Happened to Generic Mebendazole?

Understanding the current situation requires a brief history of mebendazole in the United States. Mebendazole was first approved by the FDA in 1974 and was widely available as an affordable generic for decades. In 2011, the manufacturer discontinued production of the generic form and the original brand Vermox, citing business reasons unrelated to safety or efficacy.

The disappearance of mebendazole from the US market created a void that shifted demand to albendazole and pyrantel pamoate. Mebendazole returned to the US in 2016 under the brand name Emverm, manufactured by Amneal Pharmaceuticals — but at a dramatically higher price. Research published in medical journals documented this price increase, noting that the medication that sold for around $5.82 per 100 mg tablet in 2011 re-entered the market as a high-priced brand product.

Is the Mebendazole Access Problem Getting Better or Worse?

In 2026, the situation is mixed. On one hand, the Emverm Savings Program (see below) has made the drug more accessible for patients with commercial insurance. On the other hand, uninsured patients and those on government insurance programs like Medicaid or Medicare still face significant cost barriers. The fundamental driver of the problem — lack of generic competition — has not changed.

Globally, mebendazole remains on the World Health Organization's List of Essential Medicines and is available in most countries at very low cost due to generic competition. The price disparity between the US and the rest of the world for this particular medication is stark.

How Much Does Mebendazole Cost in 2026?

Here's a breakdown of what mebendazole (Emverm) costs in 2026:

• Retail price (no discount): Approximately $4,287–$5,258 for 2 tablets (100 mg each)
• With GoodRx coupon: Approximately $4,287 (about 18% off retail)
• Emverm Savings Program (with commercial insurance): As low as $5 per fill (maximum savings of $80 per prescription, up to 12 uses)
• With insurance only (no savings card): Varies significantly by plan; prior authorization often required

What Should You Do Right Now?

If you have a mebendazole prescription and are struggling to fill it, here are your most important next steps:

1. Apply for the Emverm Savings Program. Visit emverm.com/savings-program or call 1-877-264-2440. Eligible commercially insured patients can pay as little as $5 per fill.
2. Use medfinder to find pharmacies with it in stock. medfinder will call pharmacies near you to find which ones have mebendazole (Emverm) available. Results are texted to you directly.
3. Ask your doctor about alternatives. If mebendazole remains inaccessible, affordable and effective alternatives exist. See our guide to mebendazole alternatives for a comparison of options including albendazole and pyrantel pamoate.
4. Don't wait too long. Intestinal worm infections like pinworm spread easily to other household members. Treating promptly — with mebendazole or an alternative — is important for preventing spread.

Looking Ahead

The mebendazole access challenge is likely to persist until generic manufacturers enter the US market and restore price competition. Until then, the Emverm Savings Program remains the best option for commercially insured patients, while albendazole (with generic versions available) is the most cost-effective prescription alternative for others.